Menu
Recruiting NCT06879210

Application of Artificial Intelligence in Precision Medicine and Healthcare

No phase Interventional Myasthenia Gravis

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Mobile device.(phone).
Who it may be relevant to
Registry conditions: Myasthenia Gravis. Basic parameters: from 20 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Taiwan
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Application of Artificial Intelligence to Construct Whole-person Precise Smart Medicine and Precise Health Care Program in Patients With Myasthenia Gravis

Overview

This study aims to propose an intelligent health robot that utilizes remote intelligent robots to assist patients with disease-related issues, enabling them to address their problems promptly.

Detailed description

Utilizing an information architecture system, a voice-based artificial intelligence program will be developed. The symptoms of major diseases and related knowledge will be input into this system to construct a dedicated disease platform. This platform will allow patients to remotely access it, enabling them to promptly understand and address disease-related issues, thereby improving convenience for patients.

Interventions

  • Device Mobile device.(phone)
    Develop a mobile device \[Disease Assistance Consultation\] to help patients promptly understand their disease and how to care for it. After a 4-week trial period, conduct interviews with participants to determine whether using the mobile device can increase participants' knowledge and improve the quality of healthcare.

Primary outcome measures

  • Can the use of a mobile device [Disease Assistance Consultation] enhance the understanding of disease care and increase knowledge related to diseases in traditional Chinese medicine? [Time frame: 4 weeks]

Eligibility criteria

Inclusion criteria

  • Patients diagnosed with myasthenia gravis by a physician.
  • Age 20 years and above.
  • Able to use a smartphone.

Exclusion criteria

  • Individuals not diagnosed with myasthenia gravis.
  • Individuals who do not use smartphones or tablets.
  • Individuals who withdraw from the group midway.
  • Individuals unwilling to participate in interviews.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Device feasibility

Study locations

Taiwan · 1 center
  • Yi Ting Yeh — New Taipei City

Identifiers

NCT: NCT06879210 · 20221210R

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗